Therefore, the HDAC isoform selectivity of HDAC inhibitors and its effects on acetylation in Tregs and cytotoxic T cells needs to be further investigated to fully encompass HDACi’s mediation of anti-tumor effects. The gene discussed is HDAC9; the disease is neoplasm.